WEISS FRED G
Insider CIK 1081534 · ACT Director · OSMT Director · WPI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OSMT Osmotica Pharmaceuticals p | F Tax w/h | 2021-08-27 | 2021-09-03 | 5,506 | $3.31 | $18.2K | 118,466 | SEC↗ |
| OSMT Osmotica Pharmaceuticals p | A Award | 2021-07-02 | 2021-07-07 | 61,188 | — | $0 | 123,972 | SEC↗ |
| OSMT Osmotica Pharmaceuticals p | F Tax w/h | 2021-06-18 | 2021-06-22 | 18,584 | $2.89 | $53.7K | 62,784 | SEC↗ |
| OSMT Osmotica Pharmaceuticals p | F Tax w/h | 2021-01-24 | 2021-01-26 | 5,505 | $4.46 | $24.6K | 81,368 | SEC↗ |
| OSMT Osmotica Pharmaceuticals p | F Tax w/h | 2020-05-21 | 2020-05-22 | 17,778 | $4.60 | $81.8K | 86,873 | SEC↗ |
| OSMT Osmotica Pharmaceuticals p | A Award | 2020-05-20 | 2020-05-22 | 38,716 | — | $0 | 104,651 | SEC↗ |
| OSMT Osmotica Pharmaceuticals p | F Tax w/h | 2020-01-28 | 2020-01-30 | 5,505 | $7.00 | $38.5K | 65,935 | SEC↗ |
| OSMT Osmotica Pharmaceuticals p | A Award | 2019-06-18 | 2019-06-19 | 37,037 | — | $0 | 71,440 | SEC↗ |
| OSMT Osmotica Pharmaceuticals p | A Award | 2019-01-24 | 2019-01-28 | 34,403 | — | $0 | 34,403 | SEC↗ |
| AGN Allergan plc | A Award | 2018-05-02 | 2018-05-04 | 1,985 | $151.07 | $299.9K | 29,675 | SEC↗ |
| AGN Allergan plc | A Award | 2017-05-04 | 2017-05-05 | 1,223 | $245.25 | $299.9K | 27,690 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2017-05-03 | 2017-05-05 | 668 | $243.76 | $162.8K | 26,467 | SEC↗ |
| AGN Allergan plc | A Award | 2016-08-08 | 2016-08-09 | 201 | $248.31 | $49.9K | 27,135 | SEC↗ |
| AGN Allergan plc | A Award | 2016-05-05 | 2016-05-09 | 1,188 | $210.34 | $249.9K | 26,934 | SEC↗ |
| ACT Actavis plc | A Award | 2015-06-05 | 2015-06-08 | 826 | $302.30 | $249.7K | 25,694 | SEC↗ |
| AGN Allergan plc | A Award | 2015-06-05 | 2015-06-30 | 826 | $302.30 | $249.7K | 25,694 | SEC↗ |
| ACT Actavis plc | F Tax w/h | 2015-06-04 | 2015-06-08 | 549 | $303.38 | $166.6K | 24,868 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2015-06-04 | 2015-06-30 | 549 | $303.38 | $166.6K | 24,868 | SEC↗ |
| ACT Actavis plc | A Award | 2014-05-09 | 2014-05-13 | 1,142 | $197.05 | $225.0K | 25,417 | SEC↗ |
| ACT Actavis plc | S Sale | 2013-11-14 | 2013-11-18 | 3,000 | $164.15 | $492.4K | 24,275 | SEC↗ |
| ACT Actavis, Inc. | D To issuer | 2013-10-01 | 2013-10-02 | 27,275 | — | $0 | 0 | SEC↗ |
| ACT Actavis plc | A Award | 2013-10-01 | 2013-10-03 | 27,275 | — | $0 | 27,275 | SEC↗ |
| ACT Actavis, Inc. | A Award | 2013-05-10 | 2013-05-14 | 1,877 | — | $0 | 27,275 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | M Exercise deriv | 2012-07-30 | 2012-07-31 | 30,000 | — | $0 | 0 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | M Exercise | 2012-07-30 | 2012-07-31 | 30,000 | $36.57 | $1.10M | 55,398 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | S Sale | 2012-07-30 | 2012-07-31 | 30,000 | $78.78 | $2.36M | 25,398 | SEC↗ |
| WPI WATSON PHARMACEUTICALS INC | A Award | 2012-05-11 | 2012-05-14 | 2,887 | — | $0 | 25,398 | SEC↗ |